Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemoradiotherapy and Surgery for Sinonasal Mucosal Melanoma
NCT05009446Phase 1Unknown
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Aug 2021
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in sinonasal mucosal melanoma (SNMM), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Conditions
sinonasal mucosal melanoma (SNMM)
Beyond the preview
Go deeper on NCT05009446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05009446.